FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
Activated Insights Announces 2025 Customer Experience Award™ Winners, Recognizing Excellence in Long-Term and Post-Acute Care
Activated Insights, the leading provider of training, recruitment, retention, experience management and recognition tools to ...
China’s influence on Panama Canal poses ‘acute risks to US national security,’ Sen. Cruz warns
China's influence on the Panama Canal is a major risk to U.S. national security, Sen. Ted Cruz told lawmakers during a Senate ...
Israel tells UN it's shutting down all UNRWA operations in Jerusalem: 'acute security risks'
Israel demands UNRWA halt operations in Jerusalem by January 30, citing Hamas ties and security risks. The move follows ...
FDA approves new type of non-opioid pain medication
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Business Wire4h
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigin ...
Cure Today5h
Galinpepimut-S Immunotherapy Has Preliminary Efficacy in Acute Myeloid Leukemia
Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...
F.D.A. Approves Drug to Treat Pain Without Opioid Effects
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
New Study Published in JAMA Network Open Finds Procedural Prescription Denials Can Increase Acute Care Utilization and Spending in Medicaid
A new study published in JAMA Network Open has found that while procedural prescription denials curb immediate drug costs, some denials result in increased acute care utilization and costs, which ...
Funding announcement for RVH will see acute care and complex continuing care units upgraded
Calling it a “game changer” for Renfrew Victoria Hospital (RVH), Renfrew-Nipissing-Pembroke MPP John Yakabuski said the ...
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...